Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2019-04-03 | 2019-04-03 |
| Drug Identification Number | 00870935 | 00870935 |
| Brand name | SINEMET CR 200/50 | SINEMET CR 200/50 |
| Common or Proper name | levodopa and carbidopa controlledrelease tablets | levodopa and carbidopa controlledrelease tablets |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | CARBIDOPA LEVODOPA | CARBIDOPA LEVODOPA |
| Strength(s) | 50MG 200MG | 50MG 200MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL | ORAL |
| Packaging size | 100TAB | 100TAB |
| ATC code | N04BA | N04BA |
| ATC description | DOPAMINERGIC AGENTS | DOPAMINERGIC AGENTS |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2019-04-01 | 2019-04-01 |
| Remaining supply date | 2019-02-11 | 2019-02-11 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Discontinuation due to Supply Chain Challenges | Discontinuation due to Supply Chain Challenges |
| Health Canada comments |